Histone deacetylases exert class specific roles in conditioning the brain and heart against acute ischemic injury.

Histone deacetylases exert class specific roles in conditioning the brain and heart against acute ischemic injury.

Ischemia-reperfusion (IR) injury comprises a significant portion of morbidity and mortality from heart and brain diseases worldwide. This enduring clinical problem has inspired myriad reports in the scientific literature of experimental interventions seeking to elucidate the pathology of IR injury....

Full description

Bibliographic Details
Main Authors:	Sverre Erik Aune, Daniel J Herr, Craig J Kutz, Donald R Menick
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-06-01
Series:	Frontiers in Neurology
Subjects:	Histone Deacetylase Inhibitors Histone Deacetylases Stroke ischemia reperfusion injury postconditioning posttranslational modification
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00145/full

Similar Items

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Inhibition of Histone Deacetylase by Butyrate Protects Rat Liver from Ischemic Reperfusion Injury
by: Jie Sun, et al.
Published: (2014-11-01)

Expression of Class I Histone Deacetylases in Insect Cells
by: Bryan, Erin E
Published: (2006)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
by: Shalome A. Bassett, et al.
Published: (2014-10-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Subcellular localization of class I histone deacetylases in the developing Xenopus tectum
by: Xia eGuo, et al.
Published: (2016-01-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
by: Jie Ran, et al.
Published: (2019-03-01)

Characterization and expression of histone deacetylase 1 (athd1) in Arabidopsis thaliana
by: Fong, Man Kim
Published: (2005)

Analysis of human histone deacetylase 6 and its associated protein Ubl90
by: Bertos, Nicholas R.
Published: (2004)

Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
by: Amit Kumar Singh, et al.
Published: (2018-06-01)

Jasmonates and Histone deacetylase 6 activate Arabidopsis genome-wide histone acetylation and methylation during the early acute stress response
by: Bhat, P., et al.
Published: (2022)

The Contribution of Histone Crotonylation to Tissue Health and Disease: Focus on Kidney Health
by: Julio M. Martinez-Moreno, et al.
Published: (2020-04-01)

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
by: Amila Suraweera, et al.
Published: (2018-03-01)

Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
by: Subhasish Tapadar, et al.
Published: (2020-10-01)

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
by: Surabhi Shukla, et al.
Published: (2020-04-01)

Epigenetic Alterations Induced by Photothrombotic Stroke in the Rat Cerebral Cortex: Deacetylation of Histone h3, Upregulation of Histone Deacetylases and Histone Acetyltransferases
by: Svetlana Demyanenko, et al.
Published: (2019-06-01)

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
by: Richard S. Laschanzky, et al.
Published: (2019-09-01)

Histone acetylation modifiers in the pathogenesis of Alzheimer’s disease
by: Xi eLu, et al.
Published: (2015-06-01)

Contribution à létude du rôle des déacétylases dhistones HDAC4 et HDAC8 dans la biologie des cellules de phénotype musculaire lisse
by: Glénisson, Wendy
Published: (2007)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
by: Anton Frühauf, et al.
Published: (2021-08-01)

The Role of Post-Translational Acetylation and Deacetylation of Signaling Proteins and Transcription Factors after Cerebral Ischemia: Facts and Hypotheses
by: Svetlana Demyanenko, et al.
Published: (2021-07-01)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
by: Shan-qi Guo, et al.
Published: (2012-06-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016-05-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
by: H. Miles Prince, et al.
Published: (2010-08-01)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
by: Donya Naz Divsalar, et al.
Published: (2020-06-01)

Histone deacetylases and their roles in mineralized tissue regeneration
by: Nam Cong-Nhat Huynh, et al.
Published: (2017-12-01)

Histone Deacetylase Inhibitors as Anticancer Drugs
by: Tomas Eckschlager, et al.
Published: (2017-07-01)

Histone deacetylase inhibitors are effective therapeutic agents in nasopharyngeal carcinoma cells.
Published: (2006)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021-01-01)

Neddylation Regulates Class IIa and III Histone Deacetylases to Mediate Myoblast Differentiation
by: Hongyi Zhou, et al.
Published: (2021-09-01)

Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems
by: Jenna M. Buckwalter, et al.
Published: (2019-05-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)